These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Role of bone marrow-derived mesenchymal stem cells in reduction of graft-versus-host disease by effecting CD4+CD25+ regulatory T cells in rats]. Tian Y; Deng YB; Huang YJ; Na XD; Li Y; Ye MH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1210-4. PubMed ID: 17204196 [TBL] [Abstract][Full Text] [Related]
9. Autologous hematopoietic stem cell transplantation in a patient with refractory seropositive myasthenia gravis: A case report. Sossa Melo CL; Peña AM; Salazar LA; Jiménez SI; Gómez ED; Chalela CM; Ayala-Castillo M; Peña IM Neuromuscul Disord; 2019 Feb; 29(2):142-145. PubMed ID: 30639064 [TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature. Zaja F; Barillari G; Russo D; Silvestri F; Fanin R; Baccarani M Acta Neurol Scand; 1997 Oct; 96(4):256-9. PubMed ID: 9325479 [TBL] [Abstract][Full Text] [Related]
11. [Durable remission attained with plasmapheresis and intravenous immunoglobulin therapy in a patient with acute exacerbation of GVHD-related myasthenia gravis]. Nakashima J; Itonaga H; Fujioka M; Chiwata M; Sawayama Y; Yoshimura S; Iwanaga H; Taguchi J; Yoshida S; Miyazaki Y Rinsho Ketsueki; 2018; 59(5):480-484. PubMed ID: 29877233 [TBL] [Abstract][Full Text] [Related]
12. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells. Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740 [TBL] [Abstract][Full Text] [Related]
18. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy]. Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144 [TBL] [Abstract][Full Text] [Related]
19. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report]. Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110 [TBL] [Abstract][Full Text] [Related]
20. Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis. Nishimura T; Inaba Y; Nakazawa Y; Omata T; Akasaka M; Shirai I; Ichikawa M Brain Dev; 2015 Sep; 37(8):808-16. PubMed ID: 25563663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]